A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
Copyright policy )A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
The new, highly contagious SARS-CoV-2 Omicron variant caused substantial breakthrough infections and has become the dominant strain in countries across the world. Omicron variants usually bear high mutations in the spike protein and exhibit considerable escape of most potent neutralization monoclonal antibodies and reduced efficacy of current COVID-19 vaccines.
- China Agricultural University China (People's Republic of)
- Third Military Medical University China (People's Republic of)
- Chinese Academy of Medical Sciences & Peking Union Medical College China (People's Republic of)
- Southern Medical University China (People's Republic of)
- Xinqiao Hospital China (People's Republic of)
SARS-CoV-2, Antibodies, Monoclonal, Antibodies, Viral, Antibodies, Neutralizing, COVID-19 Drug Treatment, Epitopes, Neutralization Tests, Vaccines and Antiviral Agents, Antibodies, Bispecific, Spike Glycoprotein, Coronavirus, Humans
SARS-CoV-2, Antibodies, Monoclonal, Antibodies, Viral, Antibodies, Neutralizing, COVID-19 Drug Treatment, Epitopes, Neutralization Tests, Vaccines and Antiviral Agents, Antibodies, Bispecific, Spike Glycoprotein, Coronavirus, Humans
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).24 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!